The only active ingredient contained in IMMUTOL® is highly purified Norwegian Beta-1,3/1,6-Glucan (NBG).

IMMUTOL® Dosage Information:
New IMMUTOL® users wishing to more quickly and fully support their immune system:
Weeks 1 and 2: 6 capsules (2250 mg) each day, 2 with each meal.
Weeks 3 and 4: 4 capsules (1500 mg) each day, 2 with breakfast and dinner.
Maintenance: 2 capsules (750 mg) each day with breakfast.

Healthy people using IMMUTOL® to maintain a healthy peak performing immune system:
The necessary immune supporting oral dose for healthy adults is 10 mg of NBG per kilogram of bodyweight per day, or 750 mg (2 capsules) for the average adult.

Glucans are high molecular substances that are composed of many glucose molecules linked together into different structures. They comprise a great variety of substances common in nature (for instance starch, cellulose, and glycogen), most of which cannot support the immune system.

The common feature of beta-1,3-glucans is a chain of glucose molecules linked together in so-called beta-1,3-linkages (the "backbone"). Beta-1,3/1,6-glucans are the only glucans capable of supporting immunity. These are beta-1,3-glucans with "branches" attached to the backbone, radiating outward like the branches on a tree.

Further complicating immunity support are the great structural variations among beta-1,3/1,6-glucans and the frequency and nature of side-chains affect the ability of the glucan to support your immune system.

In order for beta glucan molecules to support your immune system effectively, a specific molecular structure and branching between glucose molecules is required. Biotec Pharmacon developed and patented breakthrough processes for extracting the beta-1,3/1,6-glucan present in baker's yeast without damaging the branching points, ensuring that the side chains on the purified NBG molecule remain intact. Before Biotec Pharmacon's amazing extraction method, there was no way to obtain beta-1,3/1,6-glucan without damaging the delicate branches.

While other manufacturers attempt to duplicate the successes of Biotec, their yeast-derived beta glucans fail to meet the same standards. In nearly every comparison study, long branches in competing products were either severely damaged or non-existent. Without the extended branching, macrophage and other white blood cells cannot be properly supported.

Other glucans, such as beta-glucans from barley, oats and other grains, contain a large proportion of b-1,4-linakges and are ineffective with regard to macrophage support.